Phase 2 Study of OBP-301 (Telomelysin™) in Combination With Pembrolizumab and SBRT in Patients With HNSCC With Inoperable, Recurrent or Progressive Disease

Clinical trial NCT04685499 · TERMINATED

Trial details

NCT number: NCT04685499
Sponsor: Weill Medical College of Cornell University
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma With Inoperable Recurrent or Progressive Disease

Start date: 2021-05-03
Primary completion: 2022-03-08
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.